Dexmedetomidine and Propofol Show Similar Benefits in Adults on Mechanical Ventilation Dexmedetomidine and Propofol Show Similar Benefits in Adults on Mechanical Ventilation
A comparison of dexmedetomidine and propofol finds the drugs produce very similar outcomes when used for light sedation in adults receiving mechanical ventilation despite previous research suggesting dexmedetomidine was the superior choice.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - February 4, 2021 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

Johnson & Johnson Announces Submission of Application to the U.S. FDA for Emergency Use Authorization of its Investigational Single-Shot Janssen COVID-19 Vaccine Candidate
NEW BRUNSWICK, N.J., February 4, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that Janssen Biotech, Inc., has submitted an application to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) for its investigational single-dose Janssen COVID-19 vaccine candidate. The Company’s EUA submission is based on topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose vaccine met all primary and key secondary endpoints. The Company expects to have product available to ship immediately followi...
Source: Johnson and Johnson - February 4, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

COVID Cases Dropping in US, but Variants Threaten Progress COVID Cases Dropping in US, but Variants Threaten Progress
Daily case numbers nationally are down 30% from the average 2 weeks ago. Still, nearly 4000 died in the US on Wednesday.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - February 4, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Brazil Must Now Contend With Two SARS-CoV-2 Variants Brazil Must Now Contend With Two SARS-CoV-2 Variants
Preliminary research shows that the P.1 variant's prevalence is high in parts of Brazil, just as a second variant is detected, and the overlap is concerning.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 4, 2021 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

Why the World's Pandemic Response Needs More Female Voices Why the World's Pandemic Response Needs More Female Voices
A recent study suggests women are more likely to take Covid-19 seriously. But in many countries, they're going unheard.Undark (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - February 4, 2021 Category: Infectious Diseases Tags: Infectious Diseases Commentary Source Type: news

Can AstraZeneca ’s Vaccine Prevent the Spread of COVID-19 Virus?
In a new—yet to be peer-reviewed—study, the pharmaceutical company AstraZeneca and its partners at the University of Oxford report that their COVID-19 shot may not only protect against disease but also help to prevent spread of the SARS-CoV-2 virus. The news was heralded by policy makers desperate to see a vaccine that can curb spread of the disease, but scientists have been a bit more cautious. If confirmed, the results would represent a breakthrough in the COVID-19 vaccine race. So far, the shots authorized or approved around the world have shown strong protection against moderate to severe disease, but haven...
Source: TIME: Health - February 4, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

More Americans Vaccinated Than Total COVID-19 Cases More Americans Vaccinated Than Total COVID-19 Cases
More than 26.4 million people in the U.S. have received their first dose of a COVID-19 vaccine, surpassing the country's 26.3 million COVID-19 cases reported during the pandemic.WebMD Health News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - February 4, 2021 Category: Internal Medicine Tags: Infectious Diseases News Source Type: news

U.S. COVID-19 Death Toll Passes 450,000 U.S. COVID-19 Death Toll Passes 450,000
Daily COVID-19 deaths still remain high in the U.S., though they've decreased slightly from the peak of 4,466 deaths on Jan. 12.WebMD Health News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - February 4, 2021 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

Test and trace must be led by experts | Letter
We have excellent and capable people in the fields of infectious diseases, epidemiology and public health who understand the problem, writesDr Aamir AhmedIt is a remarkable admission of failure that after a year of Sars-CoV-2 community transmission, the UK does not have a functional and efficient test-and-trace system (MPs urge test and trace chief to prove system curbs spread of Covid, 3 February). This is galling, as we pride ourselves on a long tradition of scientific excellence, particularly in the fields of virology, epidemiology and public health. An excellent example of research-led policy to mitigate infectious dis...
Source: Guardian Unlimited Science - February 4, 2021 Category: Science Authors: Letters Tags: Coronavirus Infectious diseases Medical research Microbiology Science World news Conservatives Politics Source Type: news

Super Bowl-Bound Healthcare Workers Tout Vaccination as Ticket to Normalcy Super Bowl-Bound Healthcare Workers Tout Vaccination as Ticket to Normalcy
Onika St Louis, a nurse at Tampa General Hospital, said her decision to get the COVID-19 vaccine was a'no-brainer'once she did her research and considered the immunity benefits it would offer her on the pandemic front line.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - February 4, 2021 Category: Orthopaedics Tags: Infectious Diseases News Source Type: news

Delivering the 2020 USPSTF Preventive Care Recommendations Delivering the 2020 USPSTF Preventive Care Recommendations
Do the patient hours required to deliver the 2020 USPSTF recommended preventive care services place unrealistic expectations on already overwhelmed providers?American Journal of Public Health (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - February 4, 2021 Category: Infectious Diseases Tags: Public Health & Prevention Journal Article Source Type: news

We May Never Eliminate COVID-19. But We Can Learn to Live With It
When does a pandemic end? Is it when life regains a semblance of normality? Is it when the world reaches herd immunity, the benchmark at which enough people are immune to an infectious disease to stop its widespread circulation? Or is it when the disease is defeated, the last patient cured and the pathogen retired to the history books? The last scenario, in the case of COVID-19, is likely a ways off, if it ever arrives. The virus has infected more than 100 million people worldwide and killed more than 2 million. New viral variants even more contagious than those that started the pandemic are spreading across the world. And...
Source: TIME: Health - February 4, 2021 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Cover Story COVID-19 feature Magazine Source Type: news

NIH Director Francis Collins Is Fighting This Coronavirus While Preparing for the Next One
In May 2020, Dr. Francis Collins, the longtime head of the National Institutes of Health (NIH), was called to the White House to meet with Jared Kushner, the then President’s son-in-law and adviser, and Dr. Deborah Birx, the head of the White House Coronavirus Task Force. A few weeks earlier, Congress had given the NIH $1.5 billion to try to speed up the process of developing new diagnostic tests for COVID-19, and the White House, which was dubious about increasing the rate of testing, wanted to know more about what the NIH was doing. Collins is technically the boss of Dr. Anthony Fauci, but during the pandemic he ha...
Source: TIME: Health - February 4, 2021 Category: Consumer Health News Authors: Belinda Luscombe Tags: Uncategorized COVID-19 feature Magazine Source Type: news

Waning Antibody Responses in SARS-CoV-2 Infection Waning Antibody Responses in SARS-CoV-2 Infection
An examination of SARS-CoV-2 neutralizing antibodies shows how immunity may wane over time.Emerging Infectious Diseases (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - February 4, 2021 Category: Radiology Tags: Infectious Diseases Journal Article Source Type: news

New combination therapy offers chance of healing hepatitis B
(German Center for Infection Research) Around 260 million people, more than three percent of the global population, are chronically infected with the hepatitis B virus (HBV); in the long term, this often leads to complications such as liver cirrhosis and liver cancer. A cure is not yet possible with the available medication. Scientists at the German Center for Infection Research (DZIF) and the University Hospital Eppendorf (UKE) have now investigated a new combination therapy that has proven highly effective in their infection model. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 4, 2021 Category: Infectious Diseases Source Type: news

View the Feb. 9 AAAS Kavli Science Journalism Awards ceremony
(American Association for the Advancement of Science) Join us on Tuesday, Feb. 9., for the AAAS Kavli Science Journalism Awards ceremony, to be held in conjunction with the virtual 2021 AAAS Annual Meeting. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 4, 2021 Category: Infectious Diseases Source Type: news

Emory MVA COVID-19 vaccine safe and effective in animal models
(Emory Health Sciences) Yerkes NPRC/Emory University researchers have developed a COVID-19 vaccine that has proven safe and effective in mice and monkeys. The Emory MVA COVID-19 vaccine uses modified vaccinia Ankara (MVA) to induce strong neutralizing antibodies and killer CD8 T cells. Researchers say the vaccine is easily adaptable to address variants, can be used in combination with existing vaccines to improve their ability to combat variants and may be equally effective with a single dose. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 4, 2021 Category: Infectious Diseases Source Type: news

COVID-19 vaccine from new vaccine platform effective in mice
(Karolinska Institutet) It is necessary to develop additional COVID-19 vaccines, as different vaccine approaches have their advantages and disadvantages and may work synergistically. Researchers at Karolinska Institutet in Sweden now report that they have developed a prototype vaccine against SARS-CoV-2 using a DNA vaccine platform that is inexpensive, stable, easy to produce, and shows a good safety profile. A study published inScientific Reports shows that the vaccine induces potent immune responses in mice. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 4, 2021 Category: Infectious Diseases Source Type: news

Study shows flu vaccine lessens COVID-19 symptoms in children
(University of Missouri-Columbia) Researchers from the University of Missouri School of Medicine have discovered that children who receive a seasonal flu shot are less likely to suffer symptoms from a COVID-19 infection. The finding comes from a review of more than 900 children diagnosed with COVID-19 in 2020. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 4, 2021 Category: Infectious Diseases Source Type: news

New research to enhance air filtering in ambulances
(CranfieldUniversity) Cranfield University is working with Q-Flo, Cambridge University and NHS England to record experimental airflow data from a modern NHS ambulance under different driving conditions. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 4, 2021 Category: Infectious Diseases Source Type: news

Povidone iodine mouthwash, gargle, nasal spray to reduce nasopharyngeal viral load in patients with COVID-19
(JAMA Network) Researchers in this randomized clinical trial   investigated whether nasopharyngeal application of povidone iodine could reduce the viral load of patients with nonsevere COVID-19 symptoms. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 4, 2021 Category: Infectious Diseases Source Type: news

Electronic health records can be valuable predictor of those likeliest to die from COVID
(Massachusetts General Hospital) A study by Massachusetts General Hospital identifies key predictors of COVID-19 mortality among different age groups from patient longitudinal medical records. Predictive analytics based on electronic health records could prove valuable in allocating and distributing limited resources in the time of a pandemic. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 4, 2021 Category: Infectious Diseases Source Type: news

Spicy perfection isn't to prevent infection
(Australian National University) Spicy food is considered an example of " Darwinian gastronomy " : selection for antimicrobial ingredients to counter infection risk. By analysing over thirty thousand recipes, we show that average number of spices per recipe is more strongly associated with socioeconomic factors than infectious disease. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - February 4, 2021 Category: International Medicine & Public Health Source Type: news

Scientists establish multiple primate models of SARS-CoV-2 airborne infection
(US Army Medical Research Institute of Infectious Diseases) Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week inPLOS ONE. Their work demonstrates that any of these species may be useful for testing vaccines and therapies in response to the COVID-19 pandemic, which has resulted in over 104 million cases and more than 2 million deaths worldwide in the past year. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 4, 2021 Category: Infectious Diseases Source Type: news

Duration of antibody response varies among adults naturally reinfected with RSV
(Baylor College of Medicine) Researchers at Baylor College of Medicine found that while most individuals responded to respiratory syncytial virus (RSV) natural reinfection with a typical sustained antibody response associated with protection, a few individuals surprisingly responded atypically, not being able to sustain the antibody response, which declined to levels that made the individuals susceptible to RSV reinfection. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 4, 2021 Category: Infectious Diseases Source Type: news

A personal benefit of social distancing: lower odds of getting COVID-19
(Ohio State University) Considering the greater good by social distancing during a pandemic turns out to have an attractive personal benefit: A new study has found that staying away from others also reduces an individual person's chances of contracting COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 4, 2021 Category: Infectious Diseases Source Type: news

Zinc may help with fertility during COVID-19 pandemic, researchers report
(Wayne State University - Office of the Vice President for Research) Wayne State University School of Medicine researchers have reported that zinc supplements for men and women attempting to conceive either naturally or through assisted reproduction during the COVID-19 pandemic may prevent mitochondrial damage in young egg and sperm cells. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 4, 2021 Category: Infectious Diseases Source Type: news

The Lancet Public Health: Weekly testing and two-week isolation most cost-effective strategy to control spread of COVID-19 in high transmission areas, US study suggests
(The Lancet) Weekly COVID-19 testing, coupled with a two-week isolation period for positive cases, may be the most cost-effective strategy to tackle the spread of SARS-CoV-2 in the USA when transmission is high until vaccines are widely available, a modelling study published in The Lancet Public Health journal suggests. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 4, 2021 Category: Infectious Diseases Source Type: news

Repeated testing for COVID-19 is vital, economic and public health analysis shows
(University of Texas at Austin) Epidemiologists at The University of Texas at Austin and other institutions have a new analysis that shows the value of having all people in the U.S. tested on a regular, rotating basis to slow the spread of the novel coronavirus and the loss of life from COVID-19. In a paper in The Lancet Public Health, the paper is relevant as the U.S. weighs options to control the spread of COVID-19 through increased testing. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 4, 2021 Category: Infectious Diseases Source Type: news

People infected with COVID-19 have a higher risk of dying after a cardiac arrest
(European Society of Cardiology) COVID-19 patients who suffer a cardiac arrest either in or out of hospital are far more likely to die than patients who are not infected with the coronavirus. In particular, women have the highest risk of dying: they are nine times more likely to die after suffering a cardiac arrest in hospital, according to research published in theEuropean Heart Journal. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 4, 2021 Category: Infectious Diseases Source Type: news

Severely frail individuals with COVID-19 are three times more likely to die, study finds
(University of Birmingham) New research led by the University of Birmingham has revealed for the first time the extent to which frailty increases the risk of mortality in COVID-19 patients. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 4, 2021 Category: Infectious Diseases Source Type: news

Rollout of COVID Monoclonal Antibodies Lacked Joint Plan: Experts Rollout of COVID Monoclonal Antibodies Lacked Joint Plan: Experts
Not enough thought was given to the administration and reimbursement for the therapies, according to a new expert report.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 4, 2021 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

REVEAL Lite 2 Risk Calculator Offers Simplified Model to Assess One-Year Mortality Risk Status in Patients with Pulmonary Arterial Hypertension (PAH)
SOUTH SAN FRANCISCO, CA – February 3, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from an analysis determining the validity of the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL) Lite 2 risk calculator, an abridged version of the REVEAL 2.0 risk calculator, in patients with pulmonary arterial hypertension (PAH), a rapidly progressive disease with no known cure.[1],[2],[3] The analysis showed that REVEAL Lite 2 offers a simplified method of risk assessment using six non-invasive and modifiable variables that may be implemented routinely in...
Source: Johnson and Johnson - February 3, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Covid coughing study suggests NHS staff at far greater risk than thought
Exclusive: Health service urged to rethink safety for frontline staff and provide better PPE and ventilationCoronavirus – latest updatesSee all our coronavirus coverageThe NHS has been urged to rethink safety for thousands of frontline staff after new research suggested that Covid patients ’ coughing is putting them at far greater risk of catching the virus than previously thought.The study found that coughing generated at least 10 times more infectious “aerosol” particles than speaking or breathing – which could explain why so many NHS staff have fallen ill during the pandemic.Continue readin...
Source: Guardian Unlimited Science - February 3, 2021 Category: Science Authors: Linda Geddes Tags: Coronavirus Infectious diseases Medical research Science UK news Health NHS Society Source Type: news

Altruism would undermine UK vaccine strategy | Letters
Donating your jab would undermine the rationale behind the prioritisation scheme, writesJohn Main.Plus letters fromRuth EversleyandLinda MurgatroydIt would be noble to give your vaccine slot to others (Letters, 2 February), but it would undermine the rationale behind the prioritisation scheme. The elderly and vulnerable are hugely more likely to get seriously ill if they catch Covid and require hospitalisation. The chief aim of the strategy is to prevent the NHS being even more overwhelmed. So your morally responsible readers would, as well as forgoing vaccination, also need to refuse hospitalisation should they catch Covi...
Source: Guardian Unlimited Science - February 3, 2021 Category: Science Authors: Letters Tags: Vaccines and immunisation Coronavirus Infectious diseases Medical research Microbiology Science Health Society World news Older people Source Type: news

' Escape Mutations' May Drive New COVID Resurgence'Escape Mutations' May Drive New COVID Resurgence
The CDC and World Health Organization have called it a'variant of concern'because it has developed changes to its genetic code that make it more menacing than the original version of the virus.WebMD Health News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - February 3, 2021 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

Black COVID-19 Vaccine Hesitancy Rooted in Mistrust, Fear Black COVID-19 Vaccine Hesitancy Rooted in Mistrust, Fear
African Americans have the lowest rate of vaccination among any ethnic group. In fact, White Americans are being vaccinated at a rate 3 times higher than Black Americans.WebMD Health News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - February 3, 2021 Category: Internal Medicine Tags: Infectious Diseases News Source Type: news

The UK and South African Covid-19 variants are cause for vigilance, not panic | Julian Tang
Even a partially protective vaccine may reduce the risk of more severe illness. But that doesn ’t mean we can let our guard downJulian Tang is a clinical virologist and honorary associate professor at the University of LeicesterCoronavirus – latest updatesSee all our coronavirus coverageIt ’s hard to believe, but Covid-19 has been with us formore than a year, and like the rest of us, it is beginning to adapt. It isn ’t unique in this regard – we know that viruses mutate all the time as they make mistakes during replication. Once a virus has entered a human host, it needs to find the right cell...
Source: Guardian Unlimited Science - February 3, 2021 Category: Science Authors: Julian Tang Tags: Coronavirus Infectious diseases Medical research Microbiology Science South Africa Brazil UK news Source Type: news

A Scandal Erupts Over Vaccination Startup Led by 22-Year-Old A Scandal Erupts Over Vaccination Startup Led by 22-Year-Old
It started as a group of college friends who wanted to help during the pandemic. They had tech skills, so they used 3D printers to make face shields.Kaiser Health News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - February 3, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Bayer and Rentschler to Help Produce CureVac's COVID-19 Shot Bayer and Rentschler to Help Produce CureVac's COVID-19 Shot
CureVac has signed up pharmaceuticals giant Bayer and contract drugmaker Rentschler to help to produce its experimental COVID-19 vaccine, joining the global push to boost vaccine supplies.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - February 3, 2021 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

UK Virus Variant Has Developed Concerning New Mutation in Small Number of Cases UK Virus Variant Has Developed Concerning New Mutation in Small Number of Cases
The UK variant of the coronavirus has developed a new, concerning mutation in a small number of cases, which scientists said makes it similar to the South African and Brazilian variants and could reduce the efficacy of vaccines.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - February 3, 2021 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

UK passes 10m Covid vaccination milestone
About 15% of Britain ’s population have had their first coronavirus jab, latest figures revealCoronavirus – latest updatesSee all our coronavirus coverageBritain has given a first dose of a coronavirus vaccine to more than 10 million people as public health experts called on ministers to target future vaccinations in hotspots where the disease is threatening to run out of control.Official figures from across the UK ’s four nations showed that 374,756 people received a jab on Tuesday, taking the headline total to just over the milestone at 10.02m, less than two months after the vaccination programme began....
Source: Guardian Unlimited Science - February 3, 2021 Category: Science Authors: Dan Sabbagh and Josh Halliday Tags: Coronavirus Infectious diseases Science Medical research Microbiology UK news Society Health Source Type: news

New Campaign Fights COVID-19 Vaccine Misinformation New Campaign Fights COVID-19 Vaccine Misinformation
As health care providers work against the clock to administer as many COVID-19 vaccine doses as soon as possible, logistics aren't the only thing standing in their way.WebMD Health News (Source: Medscape Pediatrics Headlines)
Source: Medscape Pediatrics Headlines - February 3, 2021 Category: Pediatrics Tags: Infectious Diseases News Source Type: news

Israel opens coronavirus vaccines to all over-16s
New age group eligible from Thursday while focus remains on older at-risk peopleCoronavirus – latest updatesSee all our coronavirus coverageIsrael ’s health ministry has said it will offer coronavirus vaccines to anyone over the age of 16, as part of a rapid campaign in which the majority of older and vulnerable people have already received shots.The ministry has told healthcare providers they can start booking appointments for the new age group starting on Thursday.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - February 3, 2021 Category: Science Authors: Oliver Holmes in Jerusalem Tags: Coronavirus Israel Middle East and North Africa World news Infectious diseases Medical research Microbiology Science Vaccines and immunisation Source Type: news

Barriers to Early Diagnosis and Treatment of HIV Barriers to Early Diagnosis and Treatment of HIV
When it comes to receiving early testing and treatment initiation for HIV, what barriers might patients with severe immunosuppression have to overcome?HIV Medicine (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - February 3, 2021 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news

Are You Prescribing Monoclonal Antibodies for COVID-19? Are You Prescribing Monoclonal Antibodies for COVID-19?
In November, the FDA approved the use of two monoclonal antibody products to treat mild to moderate symptoms of COVID-19. How much do you know about these synthetic proteins?Medscape Reader Polls (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 3, 2021 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

What happened to “flu season?” In the age of COVID, “the flu” has been reclassified as coronavirus, says epidemiologist
(Natural News) A few months ago, some infectious disease experts began warning that it would extremely difficult, as the COVID-19 pandemic lingered into the fall, for frontline healthcare providers to determine if sickness was due to the novel coronavirus or good, old-fashioned influenza. The reason, they said, is that in many respects, flu symptoms could... (Source: NaturalNews.com)
Source: NaturalNews.com - February 3, 2021 Category: Consumer Health News Source Type: news

South Africa: Teamwork and Infrastructure Behind Local Malaria Discovery, Researchers Say
[spotlight] Local scientists, as part of an international research collaboration, identified chemical compounds with antitubercular and anti-cancer properties that can now help in the fight against malaria. The compounds could halt a malaria parasite in its tracks during different stages of the parasite's life cycle. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - February 3, 2021 Category: Infectious Diseases Source Type: news

Belgian regulators advise against giving AstraZeneca Covid vaccine to over-55s
Advisory body suggests Oxford jab should be given only to younger people for time beingCoronavirus – latest updatesSee all our coronavirus coverageRegulators in Belgium are the the latest in Europe to advise against the administration of the Oxford/AstraZeneca vaccine to older people due a lack of data about its efficacy.Frank Vandenbroucke, Belgium ’s health minister, said the country’s superior health council, an advisory body, had suggested the jab should be administered to people younger than 55 for the time being.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - February 3, 2021 Category: Science Authors: Daniel Boffey in Brussels Tags: Belgium Coronavirus Vaccines and immunisation Europe Infectious diseases Medical research Microbiology Science World news Source Type: news

24/7 Covid vaccination service unlikely in near future, says Hancock
Limited supplies and preference for daytime jabs mean PM ’s plan may not be delivered soonCoronavirus – latest updatesSee all our coronavirus coverageBoris Johnson ’s promise to set up a 24/7 Covid vaccination service is unlikely to be delivered in the near future, the health secretary has indicated.Matt Hancock said there was insufficient supply of jabs to extend the operation, which focuses on daytime inoculations. Even if there were, he added, few staff and members of the public were keen on nighttime vaccinations.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - February 3, 2021 Category: Science Authors: Kevin Rawlinson Tags: Coronavirus UK news Boris Johnson Matt Hancock Infectious diseases Medical research Microbiology Politics Science Vaccines and immunisation Source Type: news